Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 5,600
- Avg volume
- —
- Day's range
- $0.21 – $0.21
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops water-soluble solution for livestock producers under the FarmPhage name; poultry health products under the AviPhage name; food safety products under the PhageFend name; and...
Show more
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops water-soluble solution for livestock producers under the FarmPhage name; poultry health products under the AviPhage name; food safety products under the PhageFend name; and bovine mastitis products under the BoviPhage name. Cytophage Technologies Ltd. is headquartered in Oak Bluff, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Website
- https://cytophage.com
- Address
- 400 Fort Whyte Way, Suite 200A, Oak Bluff, Canada
Latest news
No headlines yet.
